IMHO, they would need to raise $1.5 to 2 million to complete studies and continue operations. At the current price ($0.03), that means they would need to issue 60 million shares, and that means that the current major shareholder (Dr. G (CEO) and Mr. Tabn. chairman) would lose majority and chunk of cardio. Therefore, they need to get the prce at a decent level, such as atleast $0.10 t0 0.12, and raise the required funds by issuing 20 million shares. this was what they were trying to raise last year with the Polish investors but it fell through because they could not get Cardio co-listed in Poland..